Spotlight On... Novartis' troubled Alcon unit recalls eye drops for sterility, potency problems; Endo tanks on women's health sale; AZ sells rights to constipation drug; Denmark vies for EMA; and more...
2021 Annual Report Wrapper
Alcon Announces Results of 2023 Annual General Meeting
Thomas Glanzmann - Director at Alcon | The Org
Untitled
Aerie raids Alcon again, returning this time with an R&D VP | Fierce Biotech
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3T4T5OVXSBPCFG3X5KLSKUSBI4.jpg "ALCC.S - | Stock Price & Latest News | Reuters")
ALCC.S - | Stock Price & Latest News | Reuters
Alcon CEO And Leadership: Executives and Demographics - Zippia
F. Michael Ball News & Articles | Crain's Chicago Business
Michael Onuscheck Net Worth (2023) | wallmine
Alcon - Governance - Board of Directors
F. Michael Ball Net Worth (2023) | wallmine
F. Michael Ball — CEO, Alcon at Novartis | Comparably
Alcon CEO And Leadership: Executives and Demographics - Zippia
Alcon Stock Forecast, price, news, analysis (ALC) | Strike.Market
PR%F the Magazine June 2022 by Food & Beverage Magazine - Issuu
Alcon - Governance - Board of Directors
Meet Our Board - Ophthalmology Foundation
17. Alcon (Novartis AG) | Medical Product Outsourcing
Alcon - Governance - Board of Directors
Mike Ball, Alcon Inc: Profile and Biography - Bloomberg Markets
Alcon - Governance - Board of Directors
Thomas Glanzmann - Director at Alcon | The Org
Michael F. Land - Wikipedia
